The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlphawave Ip Regulatory News (AWE)

Share Price Information for Alphawave Ip (AWE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 122.40
Bid: 121.80
Ask: 122.40
Change: 4.60 (3.90%)
Spread: 0.60 (0.493%)
Open: 119.20
High: 122.60
Low: 119.00
Prev. Close: 117.80
AWE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Alphawave IP Group plc - Post Stabilisation Notice

28 May 2021 07:01

RNS Number : 1115A
Barclays Capital Securities Limited
28 May 2021
 

POST-STABILISATION NOTICE

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR ANY JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE UNLAWFUL.

 

28 May 2021

Alphawave IP Group plcPost-Stabilisation Period Announcement

Further to the pre-stabilisation period announcement dated 13 May 2021, Barclays Capital Securities Limited (Contact: Ben Newmark; Telephone: +44 20 3134 8574) hereby gives notice that the Stabilising Manager named below and its affiliates undertook stabilisation in accordance with the relevant provisions of the Market Abuse Regulation (EU) No 596/2014 (as it forms part of retained EU law as defined in the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as it forms part of retained EU law as defined in the European Union (Withdrawal) Act 2018.

 The securities

Issuer

Alphawave IP Group plc

Securities

Ordinary Shares of £1 each

ISIN

GB00BNDRMJ14

Offering Size

208,695,652 Ordinary Shares excluding the over-allotment option

Description

Initial Public Offering of Ordinary Shares

Offer price

410 pence per Ordinary Share

Stabilising Manager

Barclays Capital Securities Limited, 5 The North Colonnade, Canary Wharf, London E14 4BB

Stabilisation started on:

13 May 2021

Stablisation last occurred on:

27 May 2021

Stabilisation Trading Venue(s):

London Stock Exchange

 

Stabilisation transactions:

For each of the dates during which stabilisation transactions were carried out, the price range was as follows:

Execution Date

Aggregate Quantity of Shares

Buy / Sell

Lowest Price

Highest Price

Currency

Trading Venue

13 May 2021

15,652,174

Buy

320.00

410.00

GBp

London Stock Exchange

14 May 2021

2,474,118

Buy

358.00

386.75

GBp

London Stock Exchange

17 May 2021

4,300,000

Buy

362.00

380.30

GBp

London Stock Exchange

18 May 2021

3,000,000

Buy

335.00

372.00

GBp

London Stock Exchange

19 May 2021

1,842,578

Buy

322.60

337.65

GBp

London Stock Exchange

20 May 2021

819,344

Buy

324.00

340.00

GBp

London Stock Exchange

21 May 2021

1,250,000

Buy

322.00

335.00

GBp

London Stock Exchange

24 May 2021

591,942

Buy

323.50

328.00

GBp

London Stock Exchange

25 May 2021

850,000

Buy

310.00

327.50

GBp

London Stock Exchange

26 May 2021

424,192

Buy

288.00

318.00

GBp

London Stock Exchange

27 May 2021

100,000

Buy

298.50

307.00

GBp

London Stock Exchange

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

In the United Kingdom, this announcement is being distributed only to, and is directed only at, persons who: (A) (i) are "investment professionals" specified in Article 19(5) of the Financial Services and Markets Act (Financial Promotion) Order 2005 (the "Order") and/or (ii) fall within Article 49(2)(a) to (d) of the Order (and only where the conditions contained in those Articles have been, or will at the relevant time be, satisfied); and (B) are "qualified investors" within the meaning of Article 2 of the Prospectus Regulation (Regulation (EU) 2017/1129) as it forms part of retained EU law as defined in the EU (Withdrawal) Act 2018 (all such persons together being referred to as "Relevant Persons").

In any member state of the European Economic Area ("EEA") (each, a "Relevant Member State"), this announcement and any offer if made subsequently is, and will be, directed only at persons who are "qualified investors" ("Qualified Investors") within the meaning of the Prospectus Regulation (Regulation (EU) 2017/1129).

This announcement must not be acted on or relied on (i) in the United Kingdom, by persons who are not Relevant Persons, and (ii) in any member state of the EEA, by persons who are not Qualified Investors. Any investment or investment activity to which this announcement relates is available only to: (i) in the United Kingdom, Relevant Persons; and (ii) in any member state of the EEA, Qualified Investors, and will be engaged in only with such persons.

This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase any securities in the United States or any other jurisdiction. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933 as amended (the "Securities Act") and may not be offered or sold in the United States except to "qualified institutional buyers" as defined in, and in reliance on, Rule 144A under the Securities Act or another exemption from, or transaction not subject to, the registration requirements of the Securities Act. All offers and sales of securities outside of the United States will be made in reliance on, and in compliance with, Regulation S under the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States.

Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and Prudential Regulation Authority, is acting for the Issuer only in connection with the offer and will not be responsible to anyone other than the Issuer for providing the protections offered to clients of Barclays Bank PLC, nor for providing advice in relation to the offer or any matters referred to in this communication.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAARMLTMTATBJB
Date   Source Headline
1st Mar 202310:00 amRNSTotal Voting Rights
27th Feb 202312:01 pmRNSHolding(s) in Company
27th Feb 202310:57 amRNSDirector/PDMR Shareholding
27th Feb 20237:00 amRNSNotice of FY22 Results and Q1 2023 Trading
24th Feb 20235:47 pmRNSHolding(s) in Company
24th Feb 202312:02 pmRNSDirector/PDMR Shareholding
22nd Feb 20235:41 pmRNSHolding(s) in Company
22nd Feb 202312:08 pmRNSDirector/PDMR Shareholding
20th Feb 202311:41 amRNSDirector/PDMR Shareholding
15th Feb 20232:52 pmRNSDirector/PDMR Shareholding
14th Feb 20234:55 pmRNSDirector/PDMR Shareholding
14th Feb 20234:39 pmRNSHolding(s) in Company
13th Feb 20235:00 pmRNSDirector/PDMR Shareholding
3rd Feb 20235:29 pmRNSDirector/PDMR Shareholding
1st Feb 20232:14 pmRNSTotal Voting Rights
31st Jan 20235:47 pmRNSDirector/PDMR Shareholding
31st Jan 20235:46 pmRNSDirector/PDMR Shareholding
13th Jan 20237:00 amRNSCapital Markets Day 2023
13th Jan 20237:00 amRNSQ4 2022 Trading and Business Update
12th Jan 20237:09 amRNSAnnounces Appointments to its Executive Leadership
3rd Jan 20233:42 pmRNSTotal Voting Rights
7th Dec 202210:37 amRNSResult of Meeting
1st Dec 20222:41 pmRNSTotal Voting Rights
25th Nov 20229:52 amRNSDirector/PDMR Shareholding
14th Nov 20227:00 amRNSNotice of General Meeting 2022
1st Nov 202212:01 pmRNSTotal Voting Rights
27th Oct 20227:00 amRNSResults of placing in Alphawave IP Group plc
26th Oct 20224:40 pmRNSProposed placing in Alphawave IP Group plc
19th Oct 202212:32 pmRNSDirector/PDMR Shareholding
18th Oct 20222:29 pmRNSHolding(s) in Company
18th Oct 20221:28 pmRNSDirector/PDMR Shareholding
17th Oct 20225:45 pmRNSDirector/PDMR Shareholding
17th Oct 20225:44 pmRNSDirector/PDMR Shareholding
17th Oct 20227:00 amRNSQ3 2022 Traing an Business Upate
17th Oct 20227:00 amRNSQ3 2022 Trading and Business Update
13th Oct 20227:00 amRNSAcquisition of Optical DSP Developer Banias Labs
3rd Oct 20222:01 pmRNSTotal Voting Rights
30th Sep 20227:30 amRNSDirector Declaration
21st Sep 20227:00 amRNSInterim Results for six months ended 30 June 2022
1st Sep 20221:56 pmRNSTotal Voting Rights
1st Sep 20227:00 amRNSCompletion of Acquisition of OpenFive
26th Aug 20224:00 pmRNSNotice of Interim Results
26th Aug 20227:00 amRNSAcquisition of OpenFive Approved by All Regulators
3rd Aug 20226:35 pmRNSReplacement Holding(s) in Company
3rd Aug 20226:03 pmRNSHolding(s) in Company
1st Aug 202211:00 amRNSTotal Voting Rights
21st Jul 202212:14 pmRNSDirector/PDMR Shareholding
20th Jul 20223:01 pmRNSHolding(s) in Company
19th Jul 202211:43 amRNSHolding(s) in Company
19th Jul 202210:12 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.